Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 7051 to 7065 of 7689 results

  1. Nivolumab for neoadjuvant and adjuvant treatment of localised renal cell carcinoma [ID4047]

    Discontinued [GID-TA10927]

    Technology appraisal guidance
    Discontinued

  2. Pegcetacoplan for amyotrophic lateral sclerosis TS ID 10594

    In development [GID-TA11310] Expected publication date: TBC

    Technology appraisal guidance
    In development

  3. Zio Service for detecting cardiac arrhythmias (MIB101)

    This advice has been updated and replaced by NICE medical technologies guidance 52.

    Medtech innovation briefing
    Published
    28 March 2017

  4. PneuX for preventing ventilator-associated pneumonia in intensive care (MIB45)

    This advice has been updated and replaced by NICE medical technologies guidance 48.

    Medtech innovation briefing
    Published
    10 November 2015

  5. Absorb Bioresorbable Vascular Scaffold system for coronary artery disease (MIB84)

    NICE withdrew this medtech innovation briefing in November 2017 after the company stopped manufacturing Absorb because of low uptake. Some UK hospitals continue to use the technology in ongoing clinical studies.

    Medtech innovation briefing
    Published
    26 October 2016

  6. Alcohol: school-based interventions (PH7)

    This guideline has been updated and replaced by NICE guideline NG135.

    Public health guideline
    Published
    28 November 2007

  7. Physical activity and the environment (PH8)

    This guideline has been updated and replaced by NICE guideline NG90.

    Public health guideline
    Published
    23 January 2008

  8. Community engagement (PH9)

    This guidance has been updated and replaced by NICE guideline NG44.

    Public health guideline
    Published
    27 February 2008

  9. VitalPAC for assessing vital signs of patients in hospital (MIB79)

    This advice has been updated and replaced by NICE medtech innovation briefing 205.

    Medtech innovation briefing
    Published
    14 September 2016

  10. Smoking: acute, maternity and mental health services (PH48)

    This guideline has been updated and replaced by the NICE guideline on tobacco: preventing uptake, promoting quitting and treating dependence (NG209).

    Public health guideline
    Published
    27 November 2013

  11. Smoking: workplace interventions (PH5)

    This guideline has been updated and replaced by the NICE guideline on tobacco: preventing uptake, promoting quitting and treating dependence (NG209).

    Public health guideline
    Published
    25 April 2007

  12. Smoking: harm reduction (PH45)

    This guideline has been updated and replaced by the NICE guideline on tobacco: preventing uptake, promoting quitting and treating dependence (NG209).

    Public health guideline
    Last updated
    26 July 2013

  13. BMI: preventing ill health and premature death in black, Asian and other minority ethnic groups (PH46)

    This guidance has been updated and replaced by NICE guideline CG189.

    Public health guideline
    Published
    3 July 2013

  14. Tuberculosis: identification and management in under-served groups (PH37)

    This guideline has been updated and replaced by NICE guideline NG33.

    Public health guideline
    Published
    23 March 2012

  15. Smokeless tobacco: South Asian communities (PH39)

    This guideline has been updated and replaced by the NICE guideline on tobacco: preventing uptake, promoting quitting and treating dependence (NG209).

    Public health guideline
    Published
    26 September 2012